IQVIA_Rules_Based_Medicine_Logo - rgb

(+01) 512 835 8026

Email us

Type your search term and press "enter."

Superoxide Dismutase 1, soluble

Superoxide Dismutase 1, soluble

Superoxide Dismutase-1 (SOD-1) is a well characterized cytosolic scavenger of oxygen free radicals that requires copper and zinc binding to potentiate its enzymatic activity. Enzymatically, SOD-1 facilitates the dismutation of oxygen radicals to hydrogen peroxide. Defects in the gene encoding SOD-1 have been implicated in the progression of neurological diseases, including ALS, Down?s Syndrome and Alzheimer?s Disease.

Swiss-Prot Accession Number: P00441


Bibliography

Oxidative stress in drug-na?ve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders (2016) Jordan W, Dobrowolny H, Bahn S, Bernstein HG, Brigadski T Eur Arch Psychiatry Clin Neurosci

medical_services Therapy Indications
Neurological Disease

Proteomic changes in serum of first onset, antidepressant drug-na?ve major depression patients. (2014) Stelzhammer V, Haenisch F, Chan MK, Cooper JD, Steiner J, Steeb H, Martins-de-Souza D, Rahmoune H, Guest PC, Bahn S. Int J Neuropsychopharmacol. 2014 Oct;17(10):1599-608. doi: 10.1017/S1461145714000819. Epub 2014 Jun 5.

medical_services Therapy Indications
Neurological Disease

Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype (2012) Ringman JM, Elashoff D, Geschwind DH, Welsh BT, Gylys KH, Lee C, Cummings JL, Cole GM Arch Neurol. 2012 Jun 1;69(6):757-64

medical_services Therapy Indications
Neurological Disease

Plasma methionine sulfoxide in persons with familial Alzheimers disease mutations (2012) Ringman JM, Fithian AT, Gylys K, Cummings JL, Coppola G, Elashoff D, Pratico D, Moskovitz J, Bitan G Dement Geriatr Cogn Disord. 2012;33(4):219-25

medical_services Therapy Indications
Neurological Disease